ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 900

Choroid Plexus Tertiary Lymphoid Structures in Lupus: A Novel Neuro-Immune Interface

Ariel Stock1, Evan Der2, Sivan Gelb3, Ayal Ben-Zvi3 and Chaim Putterman4, 1Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Hebrew University, Jerusalem, Israel, 4Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoimmune diseases, neuropsychiatric disorders and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: 2017 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lecture

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The central nervous system (CNS) manifestations of SLE remain poorly understood. Although potentially neuropathic autoantibodies have been identified in the serum, lupus patients show inconsistent correlations between these and neuropsychiatric SLE (NPSLE). This is likely due to the highly restrictive nature of the blood brain barrier and the variability between patients in barrier dysfunction and humoral immune transmission into the CNS.

Methods: We used the MRL/MpJ-Faslpr/lpr mouse, a well-established model of lupus associated neuropsychiatric deficits, to evaluate the immune effectors responsible for CNS disease. We performed RNA sequencing, immunofluorescent phenotyping, and light and electron microscopy of brain tissue to identify signaling pathways and cellular contributors to NPSLE.

Results: We found extensive cellular infiltrates in the MRL/MpJ-Faslpr/lpr choroid plexus by 16 weeks of age, when these mice display profound cognitive deficits and depression like behavior (Figure 1). Transcriptome analysis of the choroid plexus revealed an expression signature driving tertiary lymphoid structure (TLS) formation, including elevated Cxcl13, Lta/b (lymphotoxin α/β), Ccl19, and a host of other cytokines and chemokines related to lymphoid organization. Additionally, gene ontology assessment revealed transcriptional profiles closely related to various stages of lymphocyte activation and germinal center formation. Immunofluorescent evaluation of the choroid plexus defined the cellular infiltrate in NPSLE mice to include locally proliferating B and T cells, extensive T-cell activation, and evidence of in-situ somatic hypermutation and class switch recombination and IgG+ plasma cells. Finally, the choroid plexus was found to be important in trafficking lymphocytes into the CNS, as evidenced by the routine presence of intra-epithelial lymphocytes on transmission electron microscopy. Evaluation of human lupus choroid plexus tissue is in progress.

Conclusion: Collectively, we not only determined a potential new pathway underlying neuropsychiatric lupus, we identified TLS formation in the choroid plexus as a novel mechanism through which the immune system may bypass the blood brain barrier.


Disclosure: A. Stock, None; E. Der, None; S. Gelb, None; A. Ben-Zvi, None; C. Putterman, None.

To cite this abstract in AMA style:

Stock A, Der E, Gelb S, Ben-Zvi A, Putterman C. Choroid Plexus Tertiary Lymphoid Structures in Lupus: A Novel Neuro-Immune Interface [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/choroid-plexus-tertiary-lymphoid-structures-in-lupus-a-novel-neuro-immune-interface/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/choroid-plexus-tertiary-lymphoid-structures-in-lupus-a-novel-neuro-immune-interface/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology